No association between LDL receptor and genetic variants and atorvastatin response in Jordanian hyperlipidemic patients.

Objectives: Atorvastatin is commonly used medication to achieve low levels of low-density lipoproteins (LDL). Cholesteryl ester transfer protein () and LDL receptor () genetic variants can affect the cholesterol transport and hence may affect on atorvastatin response. This study aimed to investigate the influence of LDLR , and on the efficacy of 20 mg atorvastatin among Jordanian hyperlipidemic patients.

Effect of major CYP2C19 genetic polymorphisms on eradication based on different treatment regimens.

() infection is a global issue. Its eradication in affected individuals is important to prevent several further complications that may occur if left untreated. Proton pump inhibitors (PPIs) serve an important role in the eradication regimens of .